Alzheimer’s Disease under the Purview of Graph Theory Centric Genetic Networks
DOI:
https://doi.org/10.18662/brain/12.2/199Keywords:
Alzheimer’s disease, Cell signalling networks, Genetic networks, Graph Centrality measures, Characteristic path length, Clustering coefficientAbstract
Notice that the synapsis of brain is a form of communication. As communication demands connectivity, it is not a surprise that "graph theory" is a fastest growing area of research in the life sciences. It attempts to explain the connections and communication between networks of neurons. Alzheimer’s disease (AD) progression in brain is due to a deposition and development of amyloid plaque and the loss of communication between nerve cells. Graph/network theory can provide incredible insights into the incorrect wiring leading to memory loss in a progressive manner. Network in AD is slanted towards investigating the intricate patterns of interconnections found in the pathogenesis of brain. Here, we see how the notions of graph/network theory can be prudently exploited to comprehend the Alzheimer’s disease. We begin with introducing concepts of graph/network theory as a model for specific genetic hubs of the brain regions and cellular signalling. We begin with a brief introduction of prevalence and causes of AD followed by outlining its genetic and signalling pathogenesis. We then present some of the network-applied outcome in assessing the disease-signalling interactions, signal transduction of protein-protein interaction, disturbed genetics and signalling pathways as compelling targets of pathogenesis of the disease.
References
Aggarwal, Charu & Wang, Haixun. (2010). Managing and Mining Graph Data. doi:10.1007/978-1-4419-6045-0.
Alexander-Bloch, A.F., Gogtay, N., Meunier, D., Birn, R., Clasen, L., Lalonde, F., Lenroot, R., Giedd, J. & Bullmore, E.T. (2010). Disrupted modularity and local connectivity of brain functional networks in childhood-onset schizophrenia. Frontiers in systems neuroscience, 4, 147.
Andrews, S.J., Fulton-Howard, B. and Goate, A., (2020). Interpretation of risk loci from genome-wide association studies of Alzheimer’s disease. The Lancet Neurology.
Arotaritei, D., Turnea, M., Beiu, V., & Rotariu, M. (2013). Probabilistic gate matrix for axon-inspired communication. In 2013 E-Health and Bioengineering Conference (EHB), 1-4, IEEE.
Baars, B.J. (1997). In the theater of consciousness: the workspace of the mind. Oxford University Press, New York.
Barabasi, A.L. and Oltvai, Z.N., (2004). Network biology: understanding the cell's functional organization. Nature reviews genetics, 5(2), 101-113.
Beiu, V., Rohatinovici, N. C., Dăuş, L., & Balas, V. E. (2017). Transport reliability on axonal cytoskeleton. In 2017 14th International Conference on Engineering of Modern Electric Systems (EMES), 160-163, IEEE.
Bobba, A., Amadoro, G., Valenti, D., Corsetti, V., Lassandro, R. and Atlante, A. (2013). Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively. Mitochondrion, 13(4), 298-311.
Bota, D.A., Ngo, J.K. and Davies, K.J. (2005). Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death. Free Radical Biology and Medicine, 38(5), 665-677.
Bullmore, E. & Sporns, O. (2009). Complex brain networks: graph theoretical analysis of structural and functional systems (vol 10, pg 186, 2009). Nature Reviews Neuroscience, 10.
Calderone, A., Formenti, M., Aprea, F., Papa, M., Alberghina, L., Colangelo, A.M.,et al.(2016). Comparing Alzheimer’s and Parkinson’s diseases networks using graph communitiesstructure.BMCSyst.Biol.10:25.
Chen, L., Wang, R., Li, C. and Aihara, K., (2010). Modeling biomolecular networks in cells: structures and dynamics. Springer Science & Business Media.
Chouliaras, L., Mastroeni, D., Delvaux, E., Grover, A., Kenis, G., Hof, P.R., Steinbusch, H.W., Coleman, P.D., Rutten, B.P. and van den Hove, D.L. (2013). Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients. Neurobiology of aging, 34(9), 2091-2099.
Ciryam, P., Kundra, R., Freer, R., Morimoto, R. I., Dobson, C. M., and Vendruscolo, M. (2016). A transcriptional signature of Alzheimer’s disease is associated with a:10.1073/pnas.1516604113
Combs, B., Hamel, C. and Kanaan, N.M., 2016. Pathological conformations involving the amino terminus of tau occur early in Alzheimer’s disease and are differentially detected by monoclonal antibodies. Neurobiology of disease, 94, pp.18-31.
Dehaene, S., Kerszberg, M. & Changeux, J.P. (1998). A neuronal model of a global workspace in effortful cognitive tasks. P Natl Acad Sci USA, 95, 14529-14534.
Diao, Y., Li, M., Feng, Z., Yin, J. and Pan, Y., (2007). The community structure of the human cellular signaling network. Journal of theoretical biology, 247(4), 608-615.
Dubois, B., Feldman, H.H., Jacova, C., DeKosky, S.T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G. and Meguro, K. (2007). Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. The Lancet Neurology, 6(8), 734-746.
Esterbauer, H., Schaur, R.J. and Zollner, H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free radical Biology and medicine, 11(1), 81-128.
Everitt, B.S., Landau, S., Leese, M. and Stahl, D., (2011). Cluster analysis. John Wiley & Sons
Gene Ontology Consortium, (2006). The gene ontology (GO) project in 2006. Nucleic acids research, 34(suppl_1), D322-D326.
Ghulam, A., Lei, X., Guo, M. and Bian, C. (2020). Disease-Pathway Association Prediction Based on Random Walks With Restart and PageRank. IEEE Access, 8, 72021-72038.
Goedert, M. and Spillantini, M.G. (2006). A century of Alzheimer’s disease. Science, 314(5800), 777-781.
Hallock, P., and Thomas, M. A. (2012). Integrating the Alzheimer’s disease proteome and transcriptome: a comprehensive network model of a complex disease. OMICS, 16, 37–49.
Hickman, S.E. and El Khoury, J. (2014). TREM2 and the neuroimmunology of Alzheimer’s disease. Biochemical pharmacology, 88(4), pp.495-498.
Humphries, C. E., Kohli, M. A., Nathanson, L., Whitehead, P., Beecham, G., Martin,E.,etal.(2015).IntegratedwholetranscriptomeandDNAmethylation analysis identifies gene networks specific to late-onset Alzheimer’s disease. J.Alzheimer’ssDis.44,977–987.
Iyappan, A., Kawalia, S.B., Raschka, T., Hofmann-Apitius, M. and Senger, P. (2016). NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer’s disease. Journal of biomedical semantics, 7(1), 45.
James M. Ellison, The History of Alzheimer’s Disease, October 2, 2018, https://www.brightfocus.org/Alzheimer’ss/article/history-Alzheimer’ss-disease
Jansen, I.E., Savage, J.E., Watanabe, K., Bryois, J., Williams, D.M., Steinberg, S., Sealock, J., Karlsson, I.K., Hägg, S., Athanasiu, L. and Voyle, N. (2019). Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s’s disease risk. Nature genetics, 51(3), 404-413.
Jiang, S., Tang, L., Zhao, N., Yang, W., Qiu, Y., and Chen, H. Z. (2016). A systems view of the differences between APOE ε4 carriers and non-carriers in Alzheimer’s disease. Front. Aging Neurosci. 8, 17100171
Keck, S., Nitsch, R., Grune, T. and Ullrich, O. (2003). Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer’s disease. Journal of neurochemistry, 85(1), 115-122.
Kelly, J., Moyeed, R., Carroll, C., Luo, S. and Li, X. (2020). Genetic networks in Parkinson’s and Alzheimer’s disease. Aging (Albany NY), 12(6), 5221.
Kikuchi, M., Ogishima, S., Miyamoto, T., Miyashita, A., Kuwano, R., Nakaya, J., et al. (2013). Identification of unstable network modules reveals disease modules associated with the progression of Alzheimer’s disease. PLoS One 8, e76162.
Kim, J.H. (2018). Genetics of Alzheimer’s disease. Dementia and neurocognitive disorders, 17(4), 131-136.
Kitzbichler, M.G., Henson, R.N., Smith, M.L., Nathan, P.J. & Bullmore, E.T. (2011). Cognitive effort drives workspace configuration of human brain functional networks. The Journal of neuroscience: the official journal of the Society for Neuroscience, 31, 8259-8270.
Kocahan, S. and Doğan, Z. (2017). Mechanisms of Alzheimer’s disease pathogenesis and prevention: the brain, neural pathology, N-methyl-D-aspartate receptors, tau protein and other risk factors. Clinical Psychopharmacology and Neuroscience, 15(1), 1.
Latora, V. & Marchiori, M. (2001). Efficient behavior of small-world networks. Phys Rev Lett, 87.
Latora, V. & Marchiori, M. (2003). Economic small-world behavior in weighted networks. European Physical Journal B, 32, 249-263.
Magalingam, K.B., Radhakrishnan, A., Ping, N.S. and Haleagrahara, N. (2018). Current concepts of neurodegenerative mechanisms in Alzheimer’s disease. BioMed research international, 2018.
McGeer, P.L., Itagaki, S., Boyes, B.E. and McGeer, E.G. (1988). Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer’s disease brains. Neurology, 38(8), 1285-1285.
Miller, J. A., Woltjer, R. L., Goodenbour, J. M., Horvath, S., and Geschwind, D. H. (2013). Genes and pathways underlying regional and cell type changes in Alzheimer’s disease. Genome Med. 5:48.
Nichols, E., Szoeke, C. E., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., & Awasthi, A. (2019). Global, regional, and national burden of Alzheimer’s's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(1), 88-106.
Niven, J.E. & Laughlin, S.B. (2008). Energy limitation as a selective pressure on the evolution of sensory systems. The Journal of experimental biology, 211, 1792-1804.
Okamoto, S.I., Nakamura, T., Cieplak, P., Chan, S.F., Kalashnikova, E., Liao, L., Saleem, S., Han, X., Clemente, A., Nutter, A. and Sances, S. (2014). S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death. Cell reports, 8(1), 217-228.
Priller, C., Bauer, T., Mitteregger, G., Krebs, B., Kretzschmar, H.A. and Herms, J. (2006). Synapse formation and function is modulated by the amyloid precursor protein. Journal of Neuroscience, 26(27), 7212-7221.
Rangel, C.R., Altamiranda, J. and Aguilar, J., (2016). Semantic mining based on graph theory and ontologies. Case Study: Cell Signaling Pathways. CLEI electronic journal, 19(2), 7-7.
Reitz, C., Brayne, C., & Mayeux, R. (2011). Epidemiology of Alzheimer’s disease. Nature Reviews Neurology, 7(3), 137.
Robinson, M., Lee, B. Y., & Hane, F. T. (2017). Recent progress in Alzheimer’s’s disease research, part 2: genetics and epidemiology. Journal of Alzheimer’s disease, 57(2), 317-330.
Rohatinovici, N. C., Proştean, O., & Balas, V. E. (2018). On Reliability of 3D Hammock Networks. In 2018 IEEE 12th International Symposium on Applied Computational Intelligence and Informatics (SACI), 000149-000154, IEEE.
Rosenthal, S.L. and Kamboh, M.I. (2014). Late-onset Alzheimer’s disease genes and the potentially implicated pathways. Current genetic medicine reports, 2(2), 85-101.
Rubinov M, Sporns O. (2010): Complex network measures of brain connectivity: uses and interpretations. Neuroimage 52(3), 1059-1069.
Watts, D.J. & Strogatz, S.H. (1998). Collective dynamics of ’small-world’ networks. Nature, 393, 440-442.
Yakes, F.M. and Van Houten, B. (1997). Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proceedings of the National Academy of Sciences, 94(2), 514-519.
Zalesky, A., Fornito, A., Harding, I.H., Cocchi, L., Yucel, M., Pantelis, C. & Bullmore, E.T. (2010). Wholebrain anatomical networks: does the choice of nodes matter? NeuroImage, 50, 970-983.
Zhang, B., Gaiteri, C., Bodea, L.G., Wang, Z., McElwee, J., Podtelezhnikov, A.A., et al. (2013). Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell, 153, 707–720.
Zhang, B., Tran, L., Emilsson, V., Zhu, J. (2016). Characterization of Genetic Networks Associated with Alzheimer's disease, Methods Mol Biol, 1303, 459-77.
Zixin, H., Rong, J., Panpan, W., Zhu, Y., Zhao, J., Bennett, D.A., Li, J. and Momiao, X. (2020). Shared Causal Paths underlying Alzheimer’s dementia and Type 2 Diabetes. Scientific Reports (Nature Publisher Group), 10(1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 The Authors & LUMEN Publishing House
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant this journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work, with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as an earlier and greater citation of published work (See The Effect of Open Access).
BRAIN. Broad Research in Artificial Intelligence and Neuroscience Journal has an Attribution-NonCommercial-NoDerivs
CC BY-NC-ND